Full Text View
Tabular View
No Study Results Posted
Related Studies
Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
This study has been completed.
Study NCT00292344   Information provided by The University of Texas Health Science Center, Houston
First Received: February 13, 2006   Last Updated: April 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Travelers' Diarrhea
Additional conditions recognized in this trial
Diarrhea
Dysentery
Giardiasis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Intestinal Diseases, Parasitic
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Rifaximin and loperamide
Additional drug interventions recognized in this trial
Antidiarrheals
Loperamide
Rifaximin
More general drug interventions related to this trial
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The University of Texas Health Science Center, Houston
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services